Home › Leucemia linfoblastica acuta › Washington
Studi clinici su Leucemia linfoblastica acuta nello stato di Washington
22 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi nello stato di Washington.
Città nello stato di Washington
Testo ufficiale dello studio (inglese)
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Seattle Children's, University of Washington, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
In reclutamento
Età da 1 a 25 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05621291Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- e altri 19
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età da 12 a 78 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Seattle Children's Hospital, Seattle
In reclutamentoFase 2
6 Months · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06514794The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- e altri 1
In reclutamentoFase 1/2
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Seattle Children's Hospital d/b/a Seattle Children's Research Institute, Seattle
In reclutamentoStudio osservazionale
1 Day – 17 Years · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT06274788Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 ago 2026 · NCT07224100Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
6 Months – 65 Years · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT06013423Multicenter HomeVENT: Home Values and Experiences Navigation Track
- Seattle Childrens Hospital, Seattle
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 lug 2026 · NCT06102330A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Fred Hutchinson Cancer Research Center, Seattle
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 1/2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 1/2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT03670966Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2Volontari sani benvenuti
6 Months · Tutti i sessi · Aggiornato il 29 mag 2026 · NCT04195633HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 1
Fino a 80 anni · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT03326921Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT01790152A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1806, Seattle
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 apr 2026 · NCT06051409A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 2
Età da 18 a 66 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06859424Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
Età da 1 a 60 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT03970096Pediatric Normative Markerless Movement Analysis
- Mary Bridge Children's Therapy Unit - Research & Movement Lab, Puyallup
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 3 a 25 · Tutti i sessi · Aggiornato il 9 mar 2026 · NCT06249880Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Fred Hutchinson Cancer Research Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 nov 2025 · NCT04260022Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Seattle Children's Hospital, Seattle
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.